Altitude and SARS-CoV-2 Infection in the First Pandemic Wave in Spain

Int J Environ Res Public Health. 2021 Mar 4;18(5):2578. doi: 10.3390/ijerph18052578.

Abstract

After the first pandemic wave, a nationwide survey assessed the seroprevalence of SARS-CoV-2 antibodies in Spain and found notable differences among provinces whose causes remained unclear. This ecological study aimed to analyze the association between environmental and demographic factors and SARS-CoV-2 infection by province. The seroprevalence of SARS-CoV-2 antibodies by province was obtained from a nationwide representative survey performed in June 2020, after the first pandemic wave in Spain. Linear regression was used in the analysis. The seroprevalence of SARS-CoV-2 antibodies of the 50 provinces ranged from 0.2% to 13.6%. The altitude, which ranged from 5 to 1131 m, explained nearly half of differences in seroprevalence (R2 = 0.47, p < 0.001). The seroprevalence in people residing in provinces above the median altitude (215 m) was three-fold higher (6.5% vs. 2.1%, p < 0.001). In the multivariate linear regression, the addition of population density significantly improved the predictive value of the altitude (R2 = 0.55, p < 0.001). Every 100 m of altitude increase and 100 inhabitants/km2 of increase in population density, the seroprevalence rose 0.84 and 0.63 percentage points, respectively. Environmental conditions related to higher altitude in winter-spring, such as lower temperatures and absolute humidity, may be relevant to SARS-CoV-2 transmission. Places with such adverse conditions may require additional efforts for pandemic control.

Keywords: COVID-19; SARS-CoV-2; altitude; infection transmission; population density; seroepidemiological studies.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Altitude
  • Antibodies, Viral
  • COVID-19*
  • Humans
  • Immunoglobulin G
  • Pandemics
  • SARS-CoV-2*
  • Seroepidemiologic Studies
  • Spain / epidemiology

Substances

  • Antibodies, Viral
  • Immunoglobulin G